Beam Therapeutics Inc. - COMMON STOCK (BEAM)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
101,224,395
Total 13F shares
42,797,684
Share change
+5,943,294
Total reported value
$3,419,530,423
Put/Call ratio
82%
Price per share
$80.04
Number of holders
203
Value change
+$467,392,707
Number of buys
125
Number of sells
52

Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q1 2021

As of 31 Mar 2021 Beam Therapeutics Inc. - COMMON STOCK (BEAM) had 203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 42,797,684 shares of stock of the company.
Largest 10 holders included FMR LLC, ARK Investment Management LLC, Temasek Holdings (Private) Ltd, VANGUARD GROUP INC, BlackRock Inc., Redmile Group, LLC, MWG Management Limited, HILLHOUSE CAPITAL ADVISORS, LTD., STATE STREET CORP, and Casdin Capital, LLC.
This table shows 205 institutional shareholders of the security as of 31 Mar 2021.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.